3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Specimen Handling
192
Magnetic Resonance Spectroscopy
148
Biopsy
107
pembrolizumab
85
Carboplatin
83
Cisplatin
71
Nivolumab
64
Paclitaxel
58
Radiotherapy
54
Cyclophosphamide
51
Gemcitabine
50
Dexamethasone
46
Radiation
43
Pemetrexed
38
durvalumab
37
atezolizumab
36
Rituximab
36
Lenalidomide
35
Doxorubicin
34
olaparib
33
Etoposide
33
Docetaxel
33
venetoclax
32
Bevacizumab
31
X-Rays
30
Fluorouracil
30
Disulfides
29
Taxes
28
Prednisone
28
Cytarabine
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Bupropion
×
30 days
×
Clear all
NCT05646862
2026-05-06
INAVO121
Hoffmann-La Roche
Phase 3
Active not recruiting
420 enrolled